EUCTR2021-003547-24-FR进行中（未招募）1 期
Factors influencing the COVID-19 vaccine immune response (reactogenicity and immunogenicity) according to age and presence or not of a past history of COVID-19. COVIMMUNAGE study - COVIMMUNAGE
CHU de Saint Etienne0 个研究点目标入组 200 人开始时间: 2021年6月30日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •- Volunteer aged = 18 years-old
- •- For the group WITH a past history of COVID-19 (convalescents) = subject within = 3 months after infection
- •- For the NO past history of COVID-19 (naives), subject with no known history of COVID-19
- •- Patient affiliated or entitled to a social security plan
- •- Patients who have received informed information about the study and who have co-signed a consent to participate in the study with the investigator
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •oImmunocompromised or under immunosuppressive treatment or with a pathology (chronic infections, autoimmune) that the investigator considers would impact on the immune response
- •oSubject with a history of COVID hospitalized in intensive care
- •oSubject allergic to one of the components of the vaccines used in the study
- •osubject vaccinated for COVID-19
- •oSubject with persistent symptoms of COVID-19 (long COVID)
- •oSubjects with unstable chronic pathology
- •oPersons deprived of liberty, hospitalized without consent, hospitalized for purposes other than research
- •oUnder guardianship or curatorship
- •oHaving received a vaccine in the last 30 days
研究者
相似试验
尚未招募
不适用
COVID-19 vaccination of vulnerable populations (COVULPOP)COVID-19 vaccine responseCOVID-19Inflammatory and Immune System - Normal development and function of the immune systemRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12621001492842Prof Katie Flanagan40
招募中
4 期
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune diseasePsoriatic arthritisAnkylosing spondylitisCOVID-19Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesOral and Gastrointestinal - Crohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseMusculoskeletal - Other muscular and skeletal disordersInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersInflammatory and Immune System - Rheumatoid arthritisCrohn's DiseaseRheumatoid arthritisUlcerative ColitisACTRN12621000661875Dr Ai Tran100
已完成
不适用
COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and DysregulationsImmunodeficienciesImmune DysregulationsNCT04852276National Institute of Allergy and Infectious Diseases (NIAID)308
已完成
4 期
The immune-response and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplantNL-OMON51071niversitair Medisch Centrum Groningen850
进行中（未招募）
1 期
The efficacy and safety of COVID-19 vaccination in patients with a kidney diseaseCOVID-19 is associated with increased morbidity and mortality in kidney transplant recipients (KTR) and patients with chronic kidneydisease (CKD). Therefore, potential efficacious SARS-CoV-2 vaccination would be of great clinical importance in these patients.However, SARS-CoV-2 vaccination studies have excluded KTR and patients with CKD so-far. This will be the subject of this trial.MedDRA version: 20.0Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10061105Term: DialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862MedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862MedDRA version: 23.0Level: LLTClassification code 10084462Term: SARS-CoV-2 vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 23.0Level: LLTClassification code 10084463Term: SARS-CoV-2 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-000868-30-NLRECOVAC consortium850